Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Recent CMO promotion/ announcement

<< Previous

Bullboard Posts

Next >>

Comment by unNoteableon Dec 28, 2021 12:35pm

120 Views

Post# 34265625

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Recent CMO promotion/ announcement

@ithno.. Do you rallyu expect a response to that... Noteable and his hapless followers are being led to believe that a buyout is just around the corner.

LOOK at the pps performance over the past 20 years... does this look like a company on the cusp of fantastic success...

Brad was a charlatan, and Matt seems incapable of speaking the truth... BS company, and plenty of folk wishing it to be a success.

Don't trust the pumpers on here... just LOOK at the performance of the company's timelines, disappeared trials, contractictory statements. I will be amazed if anything comes of this,.

<< Previous

Bullboard Posts

Next >>

Revolutionizing medical imaging with nanocarbon-based contrast drugs